Piyush K. Agarwal

Biography

Dr. Agarwal is a tenure-track investigator and the Head of the Bladder Cancer Section in the Urologic Oncology Branch of the National Cancer Institute, National Institutes of Health in Bethesda, MD. He received his M.D. from the Cornell (Weill) University School of Medicine in New York, New York. He then completed his urology residency at Case Western Reserve University in Cleveland, Ohio. He then went on to the University of Texas MD Anderson Cancer Center where he completed a fellowship in urologic oncology. Before coming to the NIH, Dr. Agarwal was a faculty member at the Henry Ford Hospital Vattikuti Urology Institute where he served as the Director of Robotic Bladder Surgery. Dr. Agarwal is a Board Certified and fellowship trained Urologic Oncologic Surgeon. Dr. Agarwal specializes in multidisciplinary management of bladder cancer and complex surgical techniques including robotic cystectomy and continent urinary diversions. He is also an expert in other urologic cancers including prostate, testicular, and penile carcinoma. His clinical and laboratory research focus on all aspects of bladder cancer, specifically, BCG-refractory disease and molecular targeted therapy. He is currently evaluating the addition of a vaccine to BCG in high-grade bladder cancer in a Phase II Clinical Trial.

Research Interest

1) urothelial cancer 2) bladder cancer 3) immunotherapy 4) open and robotic surgery 5) targeted therapy 6) intravesical therapy; cancer biology, cell biology, clinical research, genetics and genomics, molecular biology and biochemistry